\\nThe Position

Global Access is focused on delivering sustainable, replicable and scalable global strategies, policies and solutions. Our work aims to support the Pharma Vision and enables affiliates to drive patient access locally while maximizing the value for society, ecosystems and business. We are operating in a highly networked and agile model with stable chapters and a variety of flexible squads and work product teams and across disease areas, functions and geographies.

As one of the EU HTA (Pipeline) Leads in the Global Access Evidence Chapter you will work with colleagues across the global organization (other Global Access Chapters, development, medical affairs, commercial) and local EU market access representatives to develop brand level EU HTA strategies and evidence packages supporting decisions which determine access to Roche\\xe2\\x80\\x99s innovative offerings.

You will support the design of pivotal trials and evidence packages, identify access evidence gaps, develop risk mitigation strategies and support trade off decisions to ensure a solid basis for successful EU HTA and reimbursement decisions in Europe (and other relevant HTA markets eg. Canada, Australia, Brazil, New Zealand).

You actively engage externally to shape the EU HTA Ecosystem including the application of novel methodologies used to support EU HTA outcomes as well as subsequent payer decisions in the 27 EU markets and lead the relationship with the new EU HTA stakeholders for JSC matters.

As EU HTA comes with new external customers, requirements, frameworks and processes you will act as a pioneer in the organization and support shaping Roche`s internal approach while consistently building in learnings and assure knowledge management and transfer to enable continuous growth in this new field.

This requires strong scientific and technical HTA expertise as well as a strong understanding of HTA processes in the EU including HTA and payers hurdles, integrated evidence plans, access strategies, healthcare environments, EU affiliate pricing & reimbursement needs.

Your key responsibilities:

Work with global clinical and development teams to enable early and appropriate evidence generation in pivotal trials and beyond, identify gaps and shape mitigation strategies for EU HTA

Input into Due Diligence assessments from an Evidence/EU HTA perspective to ensure molecules developed in partnership with external companies meet EU HTA (and other HTA markets`) requirements

Support strategic brand level trade off decisions grounded in external EU HTA JSC / payer advice to enable necessary adaptation of pivotal trial design and complementary evidence plans (CDP/IEP)

Kick off and lead cross functional EU HTA teams for JSC and ensure timely and high quality EU HTA JSC briefing books

Work in close partnership with Regulatory to enable aligned Approval and HTA strategies

Ensure close and consistent collaboration with EU affiliates to ensure relevant country input and insights are included in early drug development

Drive internal PICO survey process to consistently update and amend the EU HTA Strategy accordingly in alignment with other GA chapters, global functions and EU affiliates

Represent Roche in EU HTA related external activities such as with JSC attendees

Shape internal processes, procedures and approaches according to the emerging EU HTA environment to ensure Roche`s continuous readiness and success in all EU HTA related activities

Responsible for leading internal communication and educating internal stakeholders on key developments on EU Joint HTA including set up of knowledge management system to capture learnings consistently to enable continuous internal growth in the field of EU HTA

Who you are

You believe that success comes from a growth mindset, a focus on customer needs and cultivating an environment where everyone has the opportunity to develop and grow.

Your leadership is focused on being a Visionary, Architect, Coach and Catalyst by empowering and uplifting those who work with you to maximize business impact.

You have exceptional communication and influencing skills to ensure successful interactions with internal and external stakeholders and decision makers. You bring a high level of proficiency in negotiations and similar settings. You have established and sustainable relationships with internal as well as external Stakeholders and have a high capability to quickly build and expand internal and external stakeholder networks.

You bring a strong strategic and commercial mindset at the appropriate seniority level.

Your skills and experience:

Masters or Doctoral level degree in a relevant discipline (MD, PharmD, PhD or MSc in health economics, epidemiology, public health, biostatistic, statistics or life science disciplines)

7 or more years\\xe2\\x80\\x99 pharmaceutical industry experience preferably in an EU country, regional or global access related function (or product development, regulatory, medical affairs) or an HTA / reimbursement agency

Extensive understanding of HTA (EU / national / overall), incl. regulatory bodies, process, pathways, payer needs etc. and its impact on evidence generation

Extensive knowledge of health technology assessment, clinical research and development methods and international payer evidence requirements

Hands on experience with leading a national European Health Technology Assessment Submission Strategy and operationalization; past EUnetHTA Joint Action productions (e.g. REAs, Early Dialogues) beneficial

Excellent Leadership skills to instill a mindset shift and embed EU HTA Evidence requirements into the Clinical Development Plan and the pivotal trials

Previous experience in evaluating and synthesizing data from multiple sources to inform reimbursement/access strategies and tactics to support market access decision making preferred

Previous expertise in conducting network meta-analyses (NMA) and/or the application of evolving methodologies in health economic modeling preferred

Track record of research publications and other research outputs of high quality is beneficial

Do you have any questions? Please check our FAQs and videos on

Who we are

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we\\xe2\\x80\\x99ve become one of the world\\xe2\\x80\\x99s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. .

Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.

We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

Roche is an Equal Opportunity Employer.\\n \\n \\n \\n \\n \\n

\\n\\n Roche\\n \\n\\n

\\n